Unresolved referenced work
2018
A geographical analysis of trafficking on a popular darknet market
10.1016/j.forsciint.2017.05.021 · 2017
Understanding and fighting the medicine counterfeit market
10.1016/j.jpba.2013.01.009 · 2014
Impurity fingerprints for the identification of counterfeit medicines—a feasibility study
10.1016/j.aca.2011.05.041 · 2011
A multivariate-based wavenumber selection method for classifying medicines into authentic or counterfeit classes
10.1016/j.jpba.2013.05.004 · 2013
A new methodology for detection of counterfeit Viagra® and Cialis® tablets by image processing and statistical analysis
10.1016/j.forsciint.2011.09.002 · 2012
A framework for selecting analytical techniques in profiling authentic and counterfeit Viagra and Cialis
10.1016/j.forsciint.2013.12.005 · 2014
Internet-ordered Viagra (Sildenafil Citrate) is rarely genuine
2012
Counterfeit medicines. Bitter pills
10.1136/bmj.39412.431655.ad · 2007
A review of synthetic phosphodiesterase type 5 inhibitors (PDE-5i) found as adulterants in dietary supplements
10.1016/j.jpba.2017.07.031 · 2018
Determination of PDE-5 inhibitors and appetite suppressants in adulterated dietary supplements using LC/PDA and LC/MS
10.1080/19393210.2012.656706 · 2012
Development of a comprehensive spectral library of sildenafil and related active analogues using LC–QTOF–MS and its application for screening counterfeit pharmaceuticals
10.1016/j.forsciint.2015.08.016 · 2015
Screening for multiple phosphodiesterase type 5 inhibitor drugs in dietary supplement materials by flow injection mass spectrometry and their quantification by liquid chromatography tandem mass spectrometry
10.1016/j.jpba.2012.05.017 · 2012
Screening of synthetic PDE-5 inhibitors and their analogues as adulterants: analytical techniques and challenges
10.1016/j.jpba.2013.04.037 · 2014
Profiling counterfeit cialis, Viagra and analogs by UPLC-MS
10.1016/j.forsciint.2013.03.024 · 2013
Characterization of Sildenafil analogs by MS/MS and NMR: a guidance for detection and structure elucidation of phosphodiesterase-5 inhibitors
10.1016/j.jpba.2014.03.038 · 2014
Standardless 1H NMR determination of pharmacologically active substances in dietary supplements and medicines that have been illegally traded over the Internet
10.1002/dta.1367 · 2012
Counterfeit Cialis and Viagra fingerprinting by ATR-FTIR spectroscopy with chemometry: can the same pharmaceutical powder mixture be used to falsify two medicines?
10.1016/j.forsciint.2013.01.043 · 2013
Unresolved referenced work
2011
Recent advances in the determination of elemental impurities in pharmaceuticals – status, challenges and moving frontiers
10.1016/j.trac.2016.02.001 · 2016
Unresolved referenced work
2017
Qualitative and Quantitative study of trace element in drugs (OPIUM, HASHISH, ECSTASY PILL) by PIXE and NAA
10.1142/s0129083512400335 · 2012
Study of trace impurities in heroin by neutron activation analysis
10.1023/b:jrnc.0000040888.85552.5d · 2004
Determination of elemental levels in radiopharmaceuticals by instrumental neutron activation analysis
10.1023/a:1013275005161 · 2001
Determination of trace elements in drugs by neutron activation analysis
10.1002/jps.2600530841 · 1964
Potential metal impurities in active pharmaceutical substances and finished medicinal products – a market surveillance study
10.1016/j.ejps.2015.05.028 · 2015
Elemental impurities in pharmaceutical excipients
10.1002/jps.24650 · 2015
A multi-element ICP-MS survey method as an alternative to the heavy metals limit test for pharmaceutical materials
10.1016/s0731-7085(00)00361-7 · 2000
A rapid ICP-MS screen for heavy metals in pharmaceutical compounds
10.1016/j.jpba.2004.02.023 · 2004
Determination of heavy metals in selected drug substances by inductively coupled plasma–mass spectrometry
2005
Determination of As, Bi, Cd, Co, Cr, Ga, In, Mn, Ni, Pb, Sb, Se, Sn, Te, Tl, and V in antihypertensive drugs by inductively coupled plasma mass spectrometry
2007
An overview of recent applications of inductively coupled plasma-mass spectrometry (ICP-MS) in determination of inorganic impurities in drugs and pharmaceuticals
10.1016/j.jpba.2006.07.004 · 2007
Optimization of sample preparation and a quadrupole ICP-MS measurement protocol for the determination of elemental impurities in pharmaceutical substances in compliance with USP guidelines
10.1039/c2ja30128h · 2012
Flow injection combined with ICP-MS for accurate high throughput analysis of elemental impurities in pharmaceutical products according to USP
10.1016/j.jpba.2014.02.016 · 2014
Application of LA-ICP-MS as a rapid tool for analysis of elemental impurities in active pharmaceutical ingredients
10.1016/j.jpba.2013.12.025 · 2014
Liquid chromatography–high resolution mass spectrometry (LC–HRMS) determination of stimulants, anorectic drugs and phosphodiesterase 5 inhibitors (PDE5I) in food supplements
10.1016/j.jpba.2014.06.011 · 2015
EFSA panel on food additives and nutrient sources added to food (ANS). Scientific opinion on the re-evaluation of aspartame (E 951) as a food additive
2013
Unresolved referenced work
Kept as external metadata until matched
A snapshot on NPS in Italy: distribution of drugs in seized materials analysed in an Italian forensic laboratory in the period 2013–2015
10.1016/j.forsciint.2016.01.037 · 2016
Inorganic profiling of amoxicillin drugs in Ghana using PIXE technique
2019
